People Are Reporting A Frightening COVID Symptom — Here's What To Know
COVID infections cause miserable symptoms such as fever, fatigue, congestion and more. Now, though, some people infected with COVID in China are reporting a very sore throat that's been nicknamed 'razor blade throat.'
According to Google trends data, people throughout the U.S. are now, too, worried about this scary-sounding symptom and are searching for things like 'new covid variant painful symptom' and 'covid razor throat.'
Just how worried do you need to be about a super-painful sore throat during a COVID infection? Below, doctors weigh in on the supposed 'razor blade' sore throat symptom:
Some people with COVID are reporting a 'razor blade throat,' but you don't need to panic. It's nothing new.
'In the past, as new variants have come on the scene, there almost invariably have been questions about distinctive symptoms, and after a while, when you gather a lot of data, turns out not to be the case — all of these symptoms have occurred before,' said Dr. William Schaffner, a professor of preventive medicine in the department of health policy at Vanderbilt University Medical Center in Nashville, Tennessee.
Meaning, the circulating COVID variants tend to produce the same sort of symptoms and disease as the ones from years ago, Schaffner added. 'Although the more recent variants, these omicron variants, are less severe,' he said.
A very sore throat isn't specific to the circulating COVID variants, said Dr. Carrie Horn, the chief medical officer and chief of the division of hospital and internal medicine at National Jewish Health in Colorado. Instead, it's a symptom that has been associated with COVID infections for a while, Horn said.
Schaffner had not heard of the 'razor blade' sore throat symptom particularly, but has heard of people having a severe sore throat with COVID infections.
While some people can have a very sore throat that could be described as razor-like, it doesn't mean it's going to happen to everyone — and it also isn't some new, scary symptom that is associated with new COVID infections.
There is not one outstanding COVID symptom that marks an infection, said Dr. Mark Burns, an infectious disease expert at UofL Health in Louisville, Kentucky. 'A sore throat is a symptom of this, but also fever and cough and fatigue, these are all symptoms as well,' Burns added.
'To sum it all up, the symptoms, including sore throat, are really no different. There's no increased intensity based on sore throat or anything like that,' added Burns.
Here's how you can protect yourself from a COVID infection:
COVID tends to surge twice a year — once in the winter and once in the mid-to-late summer, Schaffner said.
'And so there has been a longstanding recommendation by the CDC's Advisory Committee on Immunization Practices that people who are at increased risk of getting severe COVID should actually get two COVID vaccinations a year. Obviously, one in the fall to prevent the winter increase, but another right now in order to help prevent serious disease during the late summer and early fall,' Schaffner said.
This goes for people 65 and older, younger people with underlying chronic medical conditions and pregnant people, he said.
'The recommendation is take special precautions and get that extra dose, because if we get infected ... we get that extra protection and to help keep us out of the hospital,' Schaffner said.
Wearing a mask in indoor spaces, social distancing, washing your hands often and increasing ventilation when possible are more ways to protect yourself from COVID and other respiratory viruses, too, said Burns.
If you do get sick, there are treatments available.
If you have any COVID symptoms, such as sore throat, fatigue, cough or fever, take a test to see if you have COVID. If you are infected, get in touch with your doctor, particularly if you're high-risk as there are treatments available, said Schaffner.
It's important that you talk to your primary care provider as the guidance will vary depending on your age, underlying conditions and other risk factors.
COVID is a miserable infection, Horn added. 'Over-the-counter meds help — Ibuprofen alternating with Tylenol, if you're able to take those ... there's no reason to be miserable,' Horn said. 'So, take the medicine that you are able to take to help,' she said.
It's also important to stay hydrated when you're sick even if you do have a painful sore throat. A sore throat can make hydration feel like more of a chore, but it's important to drink water and herbal teas as dehydration can further irritate the dry membranes in your throat, Horn said.
'If you are sick, it's best to keep your germs to yourself,' said Horn. This means canceling the dinner plans, not going to the party and calling out of work if you can — if you can't, wearing a tight-fitting mask is key, Horn added.
'Preventing transmission is the biggest thing that we can do to help keep everybody healthy,' Horn said.
Related...
A New COVID Variant Is Here, And It's More Transmissible — Here Are The Signs And Symptoms
RFK Jr. Wants To Take COVID Shots Away From Pregnant People — But You Can Fight Back
CDC Changes COVID Vaccine Recommendations — But Doesn't Go As Far As RFK Jr. Wanted
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Drug more deadly than fentanyl is quietly killing hundreds
A relatively unknown and dangerous opioid is killing hundreds as authorities scramble to warn people about the drug, a new report reveals. Synthetic opioids known as nitazenes, which are stronger than fentanyl and mostly come from China, have killed hundreds of people in Europe, The Wall Street Journal reports. Just trace amounts of the drug can trigger a fatal overdose. Street nitazenes can be up to 250 times as potent as heroin, and up to five times as strong as fentanyl, the Journal reports. The opioid has been found mixed into several drugs, including heroin, counterfeit painkillers and anxiety medication, according to the outlet. Nitazenes are now spreading amid the ongoing opioid crisis in the U.S. While the crisis has affected the entire nation, it has particularly impacted West Virginia and other Appalachian communities. More than 800,000 people died from opioid overdoses in the U.S. between 1999 and 2023, according to the CDC. 'Synthetic opioids in the U.S. have not been driven by demand, they have been driven wholesale by supply,' Vanda Felbab-Brown, a senior fellow at the Brookings Institution, told the Journal . 'If large criminal groups such as Albanian mafia groups, Turkish criminal groups or Italian or Mexican groups get into supplying nitazenes to Europe on a large scale, we can anticipate a massive public healthcare catastrophe.' Drug cartels in Mexico could 'easily' use their existing contacts in China-based suppliers to bring the opioids into the U.S., the Drug Enforcement Administration warned last year. However, at the time of the report, Mexican authorities had not seized any nitazene or nitazene-fentanyl mixtures in Mexico. Only 12 percent of nitazene exhibits analyzed by the DEA 'came from Southwest Border states,' the report said. U.S. authorities reported last year that they found nitazenes in at least 4,300 drug seizures since 2019, according to the Journal. Identifying the drug can be difficult, given that many overdose toxicology tests don't include nitazenes, the Journal reports. As a result, nitazenes are likely much more prevalent than official numbers might suggest, and the current death toll is likely an undercount. Nitazenes have never been approved for medical use and were first developed in Switzerland in the 1950s as an alternative to morphine, according to a September 2024 report by the Inter-American Drug Abuse Control Commission. The commission operates under the Organization of American States, a group of 34 nations that includes the U.S., Canada and Mexico. The opioids 'emerged more widely on the illicit drug market in Europe' in 2019, the commission said. Since then, the drugs have been identified on nearly every continent. Anne Jacques of North Wales told the Journal her son died of a nitazene overdose in 2023, explaining she felt like he had been 'murdered.' Jacques was initially told that her son, a healthy opera singer, died of cardiac arrest. When police found Xanax tablets in his room and evidence on his phone that he may have purchased the pills illegally, she researched drug contaminants and asked a coroner to test for nitazene. Seven months after her son's death, police told Jacques her son's pills had been contaminated with the opioid, the Journal reports. 'I basically had to investigate my own son's death,' Jacques said. Nitazenes could be the 'biggest public health crisis for people who use drugs in the U.K. since the AIDS crisis in the 1980s,' Vicki Markiewicz, executive director for the drug and alcohol treatment organization Change Grow Live, told the Journal.
Yahoo
an hour ago
- Yahoo
AstraZeneca seeks US drug price cuts amid expansion plans, strong demand
By Pushkala Aripaka and Maggie Fick (Reuters) -AstraZeneca has proposed price cuts to its drugs in the United States, its CEO said on Tuesday, days after unveiling a $50 billion investment to expand there, as President Donald Trump pressures pharmaceuticals companies to lower costs. Speaking to journalists after second-quarter revenue and profit beat expectations, CEO Pascal Soriot said Trump's administration was reviewing the company's proposals. He did not specify which drugs were included. Trump has repeatedly threatened tariffs as he also pushes drugmakers to reduce prices to what other countries pay. However, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any sector-specific levies take effect. "We definitely support the idea of rebalancing with some reduction of pricing levels in the U.S., and some increase, we're not talking about massive increases, in Europe," AstraZeneca's Soriot said. He added he expects all medicines for U.S. patients to be produced locally within a few months, and is also considering selling some medicines to customers directly. AstraZeneca shares rose as much as 3% after its results, but pared some gains to trade up 1.6% by 1214 GMT. "The big uncertainty, unsurprisingly, remains U.S. tariffs and Most Favoured Nation pricing in the pharmaceutical sector. AstraZeneca has looked to get ahead of this uncertainty," said Sheena Berry, a healthcare analyst at Quilter Cheviot. The U.S. accounted for more than 40% of AstraZeneca's revenue in 2024. The UK's largest-listed company by market value had prioritised the U.S. market - the world's largest, worth $635 billion - even before Trump's return to office. US BOOST AstraZeneca's efforts are paying off as strong U.S. demand, and robust sales of newer cancer, heart and kidney disease medicines drove total revenue for the second quarter 11% higher to $14.46 billion, on a constant currency basis. It logged double-digit growth in the U.S. despite headwinds from changes in U.S. Medicare price negotiations, while sales of cancer drugs including Tagrisso, Lynparza, Calquence, Truqap and Imfinzi beat expectations. Core earnings stood at $2.17 per share. Analysts were expecting $2.16, from $14.15 billion in sales, according to a company-provided consensus. AstraZeneca is betting on a wave of expected launches of 20 new medicines and its U.S. expansion to reach $80 billion in annual revenue by 2030 and offset generic competition. On Tuesday, it maintained its 2025 outlook and increased its interim dividend by 3%. The drugmaker in April forecast only a limited impact from potential U.S. tariffs, adding it would be able to meet its annual outlook if the levies on European imports were similar to those in other industries. A European Union-U.S. trade deal over the weekend will result in a 15% tariff on most goods, including pharmaceuticals, from the region.
Yahoo
2 hours ago
- Yahoo
Hospital says it never agreed to deactivate inmate's heart device before execution
NASHVILLE, Tenn. (AP) — A Tennessee hospital says it never agreed to a request by state officials who face a court order to turn off a death row inmate's heart-regulating implant before his execution next week. After a Nashville judge ordered the deactivation of Byron Black's device, a Tennessee Department of Correction official said in a court declaration that Nashville General Hospital told her they could disable it the day before his Aug. 5 execution at 10 a.m., but wouldn't come to the prison on execution day, as the judge had ordered. The judge ultimately allowed some leniency, saying Black could be moved to the hospital the morning of the execution. But on Wednesday, Nashville General Hospital spokesperson Cathy Poole said the medical center did not agree to participate at all, saying the hospital 'has no role in State executions.' The statement adds a significant complication to the court case, which relied on the state's comment about Nashville General's expected involvement. The order is under appeal, as the days dwindle before the execution. Black's attorneys say his heart device would continuously shock him in an attempt to restore his heart's normal rhythm due to the lethal injection of pentobarbital, but the state disputes that and argues that even if shocks were triggered, that Black wouldn't feel them. WPLN-FM first reported on the statement from the hospital, which said, 'Earlier reports of Nashville General Hospital's involvement are inaccurate.' 'The correctional healthcare provider contracted by the Tennessee Department of Correction (TDOC), did not contact appropriate Nashville General Hospital leadership with its request to deactivate the implanted defibrillator," Poole said. "Any assertion the hospital would participate in the procedure was premature. 'Our contract with the correctional healthcare provider is to support the ongoing medical care of its patients," Poole continued. "This request is well outside of that agreement and would also require cooperation with several other entities, all of which have indicated they are unwilling to participate.' A spokesperson for the state Department of Correction referred a request for comment to the attorney general's office, which did not immediately respond. Kelley Henry, an attorney for Black, said, 'TDOC has mishandled this situation from the beginning. My hope is that the Governor will issue a reprieve to avoid a gruesome spectacle.' Black's final appeals for a reprieve are pending in state and federal courts, and through a clemency request with GOP Gov. Bill Lee. They also include an intellectual disability claim. The state has since sought to overturn the order to deactivate Black's implantable cardioverter-defibrillator, including when and where to do it. The state Supreme Court is considering the request. The state has said the lower-court judge lacked authority to order the device disabled. The state also says the order to transport Black to the hospital the morning of the execution presents a 'very real risk of danger to TDOC personnel, hospital patients/staff, the public, and even Black,' mentioning protesters. It's about 7 miles (11 kilometers) from Riverbend Maximum Security Institution to Nashville General Hospital. Henry, Black's attorney, said the state presented 'zero evidence of security risk,' including from the frail, 69-year-old Black or the pacifists who protest executions by prayer. Henry also said state officials had not really tried to find a doctor willing to come to the prison. Black was convicted in the 1988 shooting deaths of his girlfriend Angela Clay, 29, and her two daughters, Latoya, 9, and Lakeisha, 6. Prosecutors said he was in a jealous rage when he shot the three at their home. At the time, Black was on work-release while serving time for shooting and wounding Clay's estranged husband. Black's motion related to his heart device came within a general challenge he and other death row inmates filed against the state's new execution protocol. The trial isn't until 2026. The heart device issue also has been a reminder that most medical professionals consider participation in executions a violation of medical ethics. Dan Mann, a talent booking agent and death penalty opponent who has visited Tennessee's death row for years, wrote a letter to Nashville Mayor Freddie O'Connell and metro councilmembers calling for a resolution against the city's hospital participating in pre-execution procedure. The hospital is governed by a metro Nashville authority, with board members picked by the mayor.
